Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Ann Thorac Surg. 2017 Feb 21;104(2):568–576. doi: 10.1016/j.athoracsur.2016.11.025

Fig 2.

Fig 2

Relaxation response of arterioles to bradykinin before cardioplegia arrest and cardiopulmonary bypass (pre-CP/CPB) with (squares) and without (circles) the selective cyclooxygenase (COX)-2 inhibitor NS398 from (A) no diabetes mellitus (ND) patients, (C) controlled diabetes (CDM) patients, and (E) uncontrolled diabetes (UDM) patients. The relaxation response of post-CP/CPB arterioles to bradykinin with (squares) and without (circles) the selective COX-2 inhibitor NS398 from (B) ND, (D) CDM, and (F) UDM patients. Data are mean ± standard error of the mean; n = 6 per group. *p < 0.05 versus bradykinin alone. **p < 0.001 versus bradykinin alone.